MoneyWorks4Me

Alkem Laboratories informs about disclosure

03 Dec 2020 Evaluate
Pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Alkem Laboratories has informed that it has enclosed disclosures of related party transactions, on a consolidated basis, for the half year ended on 30th September, 2020 in the prescribed format. The same have been published on the website of the Company at www.alkemlabs.com.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1781.60
Dr. Reddys Labs. 1200.90
Cipla 1336.90
Lupin 2014.00
Zydus Lifesciences 1141.50
View more..